← All organizations

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

For profitWebsite ↗

Also known as: DIZAL JIANGSU | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Dizal Pharma | Dizal Pharmaceuticals | Healthcare Research Network

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jan 31, 2026

Timeline

2010s

Oct 1, 2017
Dizal (Jiangsu) Pharmaceutical Co., Ltd.— Founded

2020s

Jul 2, 2025
sunvozertinib— Marketing Organization

Drugs by trial phase (29 distinct, 40 trials)

Phase 3 (12 own, 0 via acquisition)

Phase 2 (8 own, 0 via acquisition)

Phase 1 (9 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

sunvozertinib

Recent trials (47)

NCT07294365Lead sponsorPhase 2Jan 31, 2026
NCT07182682Lead sponsorPhase 3Oct 31, 2025
NCT07154264Lead sponsorPhase 2Sep 22, 2025
NCT07139873OfficialPhase 3Sep 8, 2025
NCT07139873Lead sponsorPhase 3Sep 8, 2025
NCT07079475Lead sponsorPhase 1/Phase 2Aug 31, 2025
NCT07059650Lead sponsorPhase 1/Phase 2Aug 19, 2025
NCT07110103CollaboratorPhase 2Aug 15, 2025
NCT07070440Lead sponsorPhase 1/Phase 2Jul 16, 2025
NCT06905197Lead sponsorPhase 1May 13, 2025
NCT06864624CollaboratorPhase 2Feb 18, 2025
NCT06813365Lead sponsorPhase 1Jun 12, 2024
NCT07234162Lead sponsorPhase 3May 13, 2024
NCT06539182Lead sponsorPhase 2Apr 29, 2024
NCT06539195Lead sponsorPhase 2Mar 13, 2024

Details

Founded: Jiangsu, CN Oct 1, 2017
Last known activity: Jan 31, 2026